This Crispr Therapeutics Stock: Why It Fell Today So Far
Biotech investors woke up to a sharp move in this crispr therapeutics stock after CRISPR Therapeutics announced new d...
Learn which dividend ETFs are inexpensive and still offer reliable income. Compare fee structures and performance to choose cost-conscious options.
20,642 articlesBiotech investors woke up to a sharp move in this crispr therapeutics stock after CRISPR Therapeutics announced new d...
Skyworks and Qorvo announce a roughly $22 billion merger aiming to close in early 2027, signaling a major shift in RF...
Oracle slipped this year, but does that mean it's a no-brainer AI buy? This practical guide weighs AI potential, fina...
Lululemon faces renewed headwinds as leadership shifts and governance questions surface. This comprehensive look brea...
A well-known money coach’s framework meets a four-million-dollar liquidity event. The question isn’t whether the math...
Himax (HIMX) faces a pivotal year as AR/VR, automotive displays, and smartphone drivers shape demand. This Q1 2026 ea...
Rapid shifts in freight markets are driving the SonicShares Global Shipping ETF's payouts. Here are the two rates boa...
A major fund is doubling down on Lionsgate Studios as shares skyrocket. Learn what know about this bet, the strategy ...
Marvell Technology stock is moving higher as demand for data center and networking chips strengthens. This guide brea...
A Deutsche Bank note over the weekend argued that the u.s. would only break an Iranian ceasefire if there was absolut...
Costco faces a pivotal question for 2029: can it sustain double-digit earnings growth and margin resilience to lift C...
Broadcom heads into a pivotal Q2 earnings report, with AI demand and data-center growth fueling momentum. This guide ...